CNS demyelination in fibrodysplasia ossificans progressiva

Substance P signaling mediates BMP-dependent heterotopic ossification

(2011) Lixin Kan et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Remyelination Is Altered by Bone Morphogenic Protein Signaling in Demyelinated Lesions

(2011) J. K. Sabo et al.   JOURNAL OF NEUROSCIENCE

Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects

(2011) Robert J Pignolo et al.   Orphanet Journal of Rare Diseases

Role of Altered Signal Transduction in Heterotopic Ossification and Fibrodysplasia Ossificans Progressiva

(2011) Eileen M. Shore et al.   Current Osteoporosis Reports

Molecular Consequences of the ACVR1R206HMutation of Fibrodysplasia Ossificans Progressiva

(2010) Gin-Ah Song et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone-induced demyelination

(2010) Holly S. Cate et al.   JOURNAL OF NEUROCHEMISTRY

Teaching NeuroImages: MRI in fibrodysplasia ossificans progressiva

(2010) R. Shiva Kumar et al.   NEUROLOGY

Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1

(2008) Frederick S. Kaplan et al.   HUMAN MUTATION